(RMS) Hermes International SCA - Ratings and Ratios

Exchange: PA • Country: France • Currency: EUR • Type: Common Stock • ISIN: FR0000052292

RMS: Leather, Clothing, Accessories, Silk, Perfumes, Watches, Jewelry

Hermès International SCA (PA:RMS), a French luxury powerhouse, epitomizes exclusivity and craftsmanship. Established in 1837, Hermès has carved a niche in high-end goods, renowned for iconic pieces like the Birkin and Kelly bags, which command premium pricing and strong resale value. Their strategy of controlled distribution and limited supply underscores their commitment to maintaining exclusivity and brand allure.

The companys diversified product portfolio spans leather goods, ready-to-wear apparel, silk textiles, and home furnishings, alongside perfumes and watches. This diversification not only mitigates risk but also broadens their market reach, appealing to a wide range of affluent consumers globally. Their emphasis on craftsmanship, with a focus on preserving traditional techniques, sets them apart in a competitive market.

Financially, Hermès boasts a market cap of 285.573 billion EUR, with a trailing P/E ratio of 64.22 and a forward P/E of 56.50, indicating anticipation of continued growth. The P/S ratio of 20.06 reflects their premium pricing strategy. As a subsidiary of H51 SAS, Hermès benefits from a stable corporate structure, which is a positive factor for investors evaluating ownership and governance.

In terms of growth, Hermès has demonstrated resilience with a revenue CAGR of 10% over the past decade, driven by robust demand in Asia. Their strategic investments in digital transformation and e-commerce highlight their adaptability to evolving retail landscapes, crucial for sustained growth in the luxury sector.

For investors, Hermès offers a unique blend of brand strength, diversification, and strategic growth initiatives. While their valuation multiples are high, reflecting their premium positioning, their ability to maintain margins through pricing power and their strong balance sheet make a compelling case for long-term investment in the luxury market.

Additional Sources for RMS Stock

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

RMS Stock Overview

Market Cap in USD 311,410m
Sector Consumer Cyclical
Industry Luxury Goods
GiC Sub-Industry Apparel, Accessories & Luxury Goods
IPO / Inception

RMS Stock Ratings

Growth 5y 79.3%
Fundamental 73.3%
Dividend 57.6%
Rel. Strength Industry 0.64
Analysts -
Fair Price Momentum 2884.95 EUR
Fair Price DCF 307.60 EUR

RMS Dividends

Dividend Yield 12m 0.54%
Yield on Cost 5y 2.08%
Annual Growth 5y 24.30%
Payout Consistency 98.6%

RMS Growth Ratios

Growth Correlation 3m 97.9%
Growth Correlation 12m 3.6%
Growth Correlation 5y 95.1%
CAGR 5y 32.62%
CAGR/Max DD 5y 0.78
Sharpe Ratio 12m 0.66
Alpha 2.62
Beta 0.82
Volatility 23.74%
Current Volume 62.7k
Average Volume 20d 59.9k
What is the price of RMS stocks?
As of February 22, 2025, the stock is trading at EUR 2749.00 with a total of 62,655 shares traded.
Over the past week, the price has changed by -3.05%, over one month by +7.43%, over three months by +38.52% and over the past year by +24.06%.
Is Hermes International SCA a good stock to buy?
Yes, based on ValueRay Fundamental Analyses, Hermes International SCA (PA:RMS) is currently (February 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 73.33 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of RMS as of February 2025 is 2884.95. This means that RMS is currently overvalued and has a potential downside of 4.95%.
Is RMS a buy, sell or hold?
Hermes International SCA has no consensus analysts rating.
What are the forecast for RMS stock price target?
According to ValueRays Forecast Model, RMS Hermes International SCA will be worth about 3461.9 in February 2026. The stock is currently trading at 2749.00. This means that the stock has a potential upside of +25.93%.
Issuer Forecast Upside
Wallstreet Target Price 2449.9 -10.9%
Analysts Target Price - -
ValueRay Target Price 3461.9 25.9%